On one hand, Kaur et al. showed a significant correlation between RUNX1 expression and inflammation, fibrosis, and NASH activity score in patients presenting NASH; they also reported RUNX1 function as a pro-angiogenic factor in SS and NASH [20]. The gene discussed is RUNX1; the disease is metabolic dysfunction-associated steatohepatitis.